# Columbus McKinnon Corp: financial statements, quarterly

CMCO · Nasdaq · CIK 1005229 · [Industrials](/sectors/industrials.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/cmco.md) · [Financials](/companies/cmco/financials.md) · [Filings](/companies/cmco/filings.md) · [Insiders](/companies/cmco/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cmco/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [258](/filings/0001005229-24-000284.md) | [254](/filings/0001005229-25-000016.md) | [266 d](/filings/0001005229-26-000022.md) | [240](/filings/0001005229-25-000205.md) | [242](/filings/0001005229-25-000240.md) | [234](/filings/0001005229-26-000011.md) | [247 d](/filings/0001005229-26-000022.md) | [236](/filings/0001005229-26-000044.md) | [261](/filings/0001005229-25-000240.md) | [259](/filings/0001005229-26-000011.md) | [438 d](/filings/0001005229-26-000022.md) | [531](/filings/0001005229-26-000044.md) |
| Cost of revenue | $m | [158](/filings/0001005229-24-000284.md) | [160](/filings/0001005229-25-000016.md) | [171 d](/filings/0001005229-26-000022.md) | [151](/filings/0001005229-25-000205.md) | [168](/filings/0001005229-25-000240.md) | [152](/filings/0001005229-26-000011.md) | [167 d](/filings/0001005229-26-000022.md) | [159](/filings/0001005229-26-000044.md) | [171](/filings/0001005229-25-000240.md) | [169](/filings/0001005229-26-000011.md) | [335 d](/filings/0001005229-26-000022.md) | [385](/filings/0001005229-26-000044.md) |
| Gross profit | $m | [100.0](/filings/0001005229-24-000284.md) | [93.9](/filings/0001005229-25-000016.md) | [94.3 d](/filings/0001005229-26-000022.md) | [89.0](/filings/0001005229-25-000205.md) | [74.7](/filings/0001005229-25-000240.md) | [82.1](/filings/0001005229-26-000011.md) | [79.8 d](/filings/0001005229-26-000022.md) | [77.2](/filings/0001005229-26-000044.md) | [90.2](/filings/0001005229-25-000240.md) | [89.2](/filings/0001005229-26-000011.md) | [103 d](/filings/0001005229-26-000022.md) | [146](/filings/0001005229-26-000044.md) |
| Research and development | $m | [6.5](/filings/0001005229-24-000284.md) | [6.7](/filings/0001005229-25-000016.md) | [7.1 d](/filings/0001005229-26-000022.md) | [6.2](/filings/0001005229-25-000205.md) | [6.1](/filings/0001005229-25-000240.md) | [5.3](/filings/0001005229-26-000011.md) | [6.3 d](/filings/0001005229-26-000022.md) | [4.8](/filings/0001005229-26-000044.md) | [4.8](/filings/0001005229-25-000240.md) | [4.4](/filings/0001005229-26-000011.md) | [7.4 d](/filings/0001005229-26-000022.md) | [8.5](/filings/0001005229-26-000044.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [33.4](/filings/0001005229-24-000284.md) | [26.9](/filings/0001005229-25-000016.md) | [25.4 d](/filings/0001005229-26-000022.md) | [21.1](/filings/0001005229-25-000205.md) | [10.8](/filings/0001005229-25-000240.md) | [17.7](/filings/0001005229-26-000011.md) | [4.9 d](/filings/0001005229-26-000022.md) | [5.5](/filings/0001005229-26-000044.md) | [12.2](/filings/0001005229-25-000240.md) | [16.2](/filings/0001005229-26-000011.md) | [(153) d](/filings/0001005229-26-000022.md) | [(17.7)](/filings/0001005229-26-000044.md) |
| Interest expense | $m | [10.2](/filings/0001005229-23-000274.md) | [10.0](/filings/0001005229-24-000016.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [5.1](/filings/0001005229-24-000284.md) | [3.9](/filings/0001005229-25-000016.md) | [2.5 d](/filings/0001005229-26-000022.md) | [3.4](/filings/0001005229-25-000205.md) | [(4.9)](/filings/0001005229-25-000240.md) | [1.9](/filings/0001005229-26-000011.md) | [(0.8) d](/filings/0001005229-26-000022.md) | [0.3](/filings/0001005229-26-000044.md) | [(1.4)](/filings/0001005229-25-000240.md) | [1.8](/filings/0001005229-26-000011.md) | [22.3 d](/filings/0001005229-26-000022.md) | [21.0](/filings/0001005229-26-000044.md) |
| Net income | $m | [15.8](/filings/0001005229-25-000016.md) | [9.7](/filings/0001005229-25-000016.md) | [11.8 d](/filings/0001005229-26-000022.md) | [8.6](/filings/0001005229-26-000011.md) | [(15.0)](/filings/0001005229-26-000011.md) | [4.0](/filings/0001005229-26-000011.md) | [(2.7) d](/filings/0001005229-26-000022.md) | [(1.9)](/filings/0001005229-26-000044.md) | [4.6](/filings/0001005229-26-000011.md) | [6.0](/filings/0001005229-26-000011.md) | [(238) d](/filings/0001005229-26-000022.md) | [(88.7)](/filings/0001005229-26-000044.md) |
| Diluted EPS | $ per share | [0.55](/filings/0001005229-24-000284.md) | [0.34](/filings/0001005229-25-000016.md) | not reported | [0.30](/filings/0001005229-25-000205.md) | [(0.52)](/filings/0001005229-25-000240.md) | [0.14](/filings/0001005229-26-000011.md) | not reported | [(0.07)](/filings/0001005229-26-000044.md) | [0.16](/filings/0001005229-25-000240.md) | [0.21](/filings/0001005229-26-000011.md) | not reported | [(2.05)](/filings/0001005229-26-000044.md) |
| Basic EPS | $ per share | [0.55](/filings/0001005229-24-000284.md) | [0.34](/filings/0001005229-25-000016.md) | not reported | [0.30](/filings/0001005229-25-000205.md) | [(0.52)](/filings/0001005229-25-000240.md) | [0.14](/filings/0001005229-26-000011.md) | not reported | [(0.07)](/filings/0001005229-26-000044.md) | [0.16](/filings/0001005229-25-000240.md) | [0.21](/filings/0001005229-26-000011.md) | not reported | [(2.05)](/filings/0001005229-26-000044.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [99.1](/filings/0001005229-23-000274.md) | [103](/filings/0001005229-24-000016.md) | [114](/filings/0001005229-25-000149.md) | [68.4](/filings/0001005229-24-000234.md) | [55.7](/filings/0001005229-24-000284.md) | [41.2](/filings/0001005229-25-000016.md) | [53.7](/filings/0001005229-26-000022.md) | [28.7](/filings/0001005229-25-000205.md) | [28.0](/filings/0001005229-25-000240.md) | [35.5](/filings/0001005229-26-000011.md) | [96.6](/filings/0001005229-26-000044.md) | [98.4](/filings/0001005229-26-000044.md) |
| Current assets | $m | [511](/filings/0001005229-23-000274.md) | [516](/filings/0001005229-24-000016.md) | [514](/filings/0001005229-25-000149.md) | [478](/filings/0001005229-24-000234.md) | [468](/filings/0001005229-24-000284.md) | [440](/filings/0001005229-25-000016.md) | [466](/filings/0001005229-26-000022.md) | [478](/filings/0001005229-25-000205.md) | [480](/filings/0001005229-25-000240.md) | [482](/filings/0001005229-26-000011.md) | [1,181](/filings/0001005229-26-000044.md) | [1,123](/filings/0001005229-26-000044.md) |
| Total assets | $m | [1,827](/filings/0001005229-23-000274.md) | [1,857](/filings/0001005229-24-000016.md) | [1,826](/filings/0001005229-26-000022.md) | [1,782](/filings/0001005229-24-000234.md) | [1,777](/filings/0001005229-24-000284.md) | [1,711](/filings/0001005229-25-000016.md) | [1,739](/filings/0001005229-26-000022.md) | [1,779](/filings/0001005229-25-000205.md) | [1,770](/filings/0001005229-25-000240.md) | [1,763](/filings/0001005229-26-000011.md) | [4,785](/filings/0001005229-26-000044.md) | [4,674](/filings/0001005229-26-000044.md) |
| Current liabilities | $m | [264](/filings/0001005229-23-000274.md) | [269](/filings/0001005229-24-000016.md) | [262](/filings/0001005229-25-000149.md) | [232](/filings/0001005229-24-000234.md) | [230](/filings/0001005229-24-000284.md) | [217](/filings/0001005229-25-000016.md) | [258](/filings/0001005229-26-000022.md) | [259](/filings/0001005229-25-000205.md) | [266](/filings/0001005229-25-000240.md) | [263](/filings/0001005229-26-000011.md) | [584](/filings/0001005229-26-000044.md) | [562](/filings/0001005229-26-000044.md) |
| Total liabilities | $m | [973](/filings/0001005229-23-000274.md) | [979](/filings/0001005229-24-000016.md) | [944](/filings/0001005229-25-000149.md) | [896](/filings/0001005229-24-000234.md) | [881](/filings/0001005229-24-000284.md) | [839](/filings/0001005229-25-000016.md) | [857](/filings/0001005229-26-000022.md) | [868](/filings/0001005229-25-000205.md) | [855](/filings/0001005229-25-000240.md) | [840](/filings/0001005229-26-000011.md) | [3,336](/filings/0001005229-26-000044.md) | [3,308](/filings/0001005229-26-000044.md) |
| Long-term debt | $m | [514](/filings/0001005229-23-000274.md) | [499](/filings/0001005229-24-000016.md) | [467](/filings/0001005229-25-000149.md) | not reported | not reported | not reported | [409](/filings/0001005229-26-000022.md) | not reported | not reported | not reported | [2,227](/filings/0001005229-26-000044.md) | [2,223](/filings/0001005229-26-000044.md) |
| Current portion of debt | $m | [50.6](/filings/0001005229-23-000274.md) | [50.7](/filings/0001005229-24-000016.md) | [50.0](/filings/0001005229-25-000149.md) | [50.0](/filings/0001005229-24-000234.md) | [50.0](/filings/0001005229-24-000284.md) | [50.0](/filings/0001005229-25-000016.md) | [50.0](/filings/0001005229-26-000022.md) | [50.0](/filings/0001005229-25-000205.md) | [50.0](/filings/0001005229-25-000240.md) | [50.0](/filings/0001005229-26-000011.md) | [166](/filings/0001005229-26-000044.md) | [154](/filings/0001005229-26-000044.md) |
| Short-term borrowings | $m | [50.0](/filings/0001005229-23-000274.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [854](/filings/0001005229-25-000016.md) | [878](/filings/0001005229-25-000016.md) | [882](/filings/0001005229-26-000011.md) | [886](/filings/0001005229-26-000011.md) | [896](/filings/0001005229-26-000011.md) | [872](/filings/0001005229-26-000011.md) | [882](/filings/0001005229-26-000022.md) | [911](/filings/0001005229-26-000011.md) | [915](/filings/0001005229-26-000011.md) | [923](/filings/0001005229-26-000011.md) | [1,449](/filings/0001005229-26-000044.md) | [1,367](/filings/0001005229-26-000044.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [16.7 d](/filings/0001005229-24-000284.md) | [29.1 d](/filings/0001005229-25-000016.md) | [38.6 d](/filings/0001005229-26-000022.md) | [(10.8)](/filings/0001005229-25-000205.md) | [9.4 d](/filings/0001005229-25-000240.md) | [11.4 d](/filings/0001005229-26-000011.md) | [35.6 d](/filings/0001005229-26-000022.md) | [(18.2)](/filings/0001005229-26-000044.md) | [18.4 d](/filings/0001005229-25-000240.md) | [20.3 d](/filings/0001005229-26-000011.md) | [(167) d](/filings/0001005229-26-000022.md) | [25.6](/filings/0001005229-26-000044.md) |
| Capital expenditure | $m | [5.0 d](/filings/0001005229-24-000284.md) | [6.0 d](/filings/0001005229-25-000016.md) | [8.5 d](/filings/0001005229-26-000022.md) | [4.6](/filings/0001005229-25-000205.md) | [5.4 d](/filings/0001005229-25-000240.md) | [5.2 d](/filings/0001005229-26-000011.md) | [6.1 d](/filings/0001005229-26-000022.md) | [3.2](/filings/0001005229-26-000044.md) | [3.3 d](/filings/0001005229-25-000240.md) | [3.8 d](/filings/0001005229-26-000011.md) | [7.5 d](/filings/0001005229-26-000022.md) | [5.7](/filings/0001005229-26-000044.md) |
| Dividends paid | $m | [2.0 d](/filings/0001005229-24-000284.md) | [2.0 d](/filings/0001005229-25-000016.md) | [2.0 d](/filings/0001005229-26-000022.md) | [2.0](/filings/0001005229-25-000205.md) | [2.0 d](/filings/0001005229-25-000240.md) | [2.0 d](/filings/0001005229-26-000011.md) | [2.0 d](/filings/0001005229-26-000022.md) | [2.0](/filings/0001005229-26-000044.md) | [2.0 d](/filings/0001005229-25-000240.md) | [2.0 d](/filings/0001005229-26-000011.md) | [2.0 d](/filings/0001005229-26-000022.md) | [2.0](/filings/0001005229-26-000044.md) |
| Share repurchases | $m | not reported | [0.0 d](/filings/0001005229-25-000016.md) | [0.0 d](/filings/0001005229-26-000022.md) | not reported | not reported | [5.0 d](/filings/0001005229-26-000011.md) | [0.1 d](/filings/0001005229-26-000022.md) | not reported | not reported | [0.0 d](/filings/0001005229-26-000011.md) | [0.0 d](/filings/0001005229-26-000022.md) | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [28.7](/filings/0001005229-23-000274.md) | [28.8](/filings/0001005229-24-000016.md) | [28.9](/filings/0001005229-24-000234.md) | [29.0](/filings/0001005229-24-000284.md) | [29.0](/filings/0001005229-25-000016.md) | [29.1](/filings/0001005229-25-000205.md) | [28.9](/filings/0001005229-25-000240.md) | [28.9](/filings/0001005229-26-000011.md) | [28.7](/filings/0001005229-26-000044.md) | [28.9](/filings/0001005229-25-000240.md) | [28.9](/filings/0001005229-26-000011.md) | [28.8](/filings/0001005229-26-000044.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 28,864,244 at 2026-07-27, from the cover of the [10-Q filed 2026-07-30](/filings/0001005229-26-000044.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.